Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lova Sun

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Molecular Oncology|November 24, 2023
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMalay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, et al.
Investigational New Drugs|May 1, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumorsRoger B Cohen, Antonio Jimeno, Jennifer Hreno, et al.
British Journal of Haematology|May 28, 2019
Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research CollaborativeVivek A Upadhyay, Benjamin P Geisler, Lova Sun, et al.
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
JAMA Network Open|February 24, 2021
Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate CancerLova Sun, Ravi B Parikh, Rebecca A Hubbard, et al.
JAMA Otolaryngology-- Head & Neck Surgery|August 18, 2022
Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint InhibitorsSara B Hobday, Robert M Brody, Barry Kriegsman, et al.
Translational Oncology|January 28, 2014
Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumorsDaniel Y Joh, Gary D Kao, Surya Murty, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 22, 2022
Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck CancerLova Sun, Danielle Candelieri-Surette, Tori Anglin-Foote, et al.
Translational Cancer Research|November 28, 2014
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitizationJay F Dorsey, Lova Sun, Daniel Y Joh, et al.
Transfusion|February 22, 2020
Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpuraMeaghan Colling, Lova Sun, Vivek Upadhyay, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Molecular Oncology|November 24, 2023
A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomasMalay K Sannigrahi, Austin C Cao, Pavithra Rajagopalan, et al.
Investigational New Drugs|May 1, 2025
Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumorsRoger B Cohen, Antonio Jimeno, Jennifer Hreno, et al.
British Journal of Haematology|May 28, 2019
Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research CollaborativeVivek A Upadhyay, Benjamin P Geisler, Lova Sun, et al.
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
JAMA Network Open|February 24, 2021
Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate CancerLova Sun, Ravi B Parikh, Rebecca A Hubbard, et al.
JAMA Otolaryngology-- Head & Neck Surgery|August 18, 2022
Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint InhibitorsSara B Hobday, Robert M Brody, Barry Kriegsman, et al.
Translational Oncology|January 28, 2014
Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumorsDaniel Y Joh, Gary D Kao, Surya Murty, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 22, 2022
Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck CancerLova Sun, Danielle Candelieri-Surette, Tori Anglin-Foote, et al.
Translational Cancer Research|November 28, 2014
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitizationJay F Dorsey, Lova Sun, Daniel Y Joh, et al.
Transfusion|February 22, 2020
Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpuraMeaghan Colling, Lova Sun, Vivek Upadhyay, et al.
Pageof 9